Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes
International Ophthalmology · 2026
DOI: 10.1007/s10792-026-04223-3 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Ophthalmology, 2026. Verfasst von Dilara Altun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Türkiye. drdilara.altun@gmail.com. Hauptthemen laut MEDLINE: Visual Acuity, Descemet Stripping Endothelial Keratoplasty, Vitrectomy, Corneal Diseases. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Purpose
To compare visual, anatomic, and graft-related outcomes after Descemet membrane endothelial keratoplasty (DMEK) in vitrectomized versus non-vitrectomized eyes, and to identify factors associated with adverse outcomes in these eyes.
Methods
This retrospective study analyzed DMEK performed between January 2018 and January 2025. Fifty-four vitrectomized eyes with pseudophakic bullous keratopathy (PBK) were compared with 50 non-vitrectomized PBK controls without major ocular comorbidity. Outcomes included best-corrected visual acuity (BCVA), central corneal thickness (CCT), endothelial cell density (ECD) and ECD loss, graft-related reinterventions, and cystoid macular edema (CME).
Results
104 eyes were analyzed. BCVA and CCT improved significantly in both groups (p < 0.001). At 12 months, vitrectomized eyes had lower ECD (1458 ± 545 vs 1759 ± 436 cells/mm^2; p = 0.030) and greater ECD loss (50.8 ± 18.6% vs 38.5 ± 15.2%; p = 0.031). CME (35.2% vs 6.0%; p < 0.001) and repeat DMEK (20.4% vs 4.0%; p = 0.016) were more frequent in vitrectomized eyes. Rebubbling (29.6% vs 16.0%) and penetrating keratoplasty (7.4% vs 0%) were more common but nonsignificant (p = 0.11, 0.12). A longer vitrectomy-to-DMEK interval was associated with CME (p = 0.013).
Conclusion
DMEK provides meaningful visual and anatomic improvement in vitrectomized eyes. However, versus controls they had greater endothelial cell loss, more frequent repeat DMEK, and markedly higher CME, whereas rebubbling and penetrating keratoplasty differences were nonsignificant. Given their heterogeneity, frequent capsular–zonular compromise, and the retrospective design, these associations warrant caution. Vitrectomized eyes represent a complex, higher-risk DMEK group warranting closer follow-up and individualized perioperative management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Türkiye. drdilara.altun@gmail.com.
- Department of Ophthalmology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Türkiye.
Zitieren
APA
Altun, D., Karaca, E. E., Önen, M., Bekmez, Ö., & Evren Kemer, Ö. (2026). Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes. International Ophthalmology. https://doi.org/10.1007/s10792-026-04223-3
Vancouver
Altun D, Karaca EE, Önen M, Bekmez Ö, Evren Kemer Ö. Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes. International Ophthalmology. 2026. doi:10.1007/s10792-026-04223-3
BibTeX
@article{Altun2026,
author = {Altun, Dilara and Karaca, Emine Esra and Önen, Mehmet and Bekmez, Öznur and Evren Kemer, Özlem},
title = {Graft outcomes, reinterventions, and macular morbidity after DMEK in vitrectomized versus non-vitrectomized eyes},
journal = {International Ophthalmology},
year = {2026},
doi = {10.1007/s10792-026-04223-3}
}
EUVIMED